Back to User profile » Dr Francis Lobo
Paper published by Dr Francis Lobo:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity
Park SH, Han X, Lobo F, Nanji S, Patel D
ClinicoEconomics and Outcomes Research 2020, 12:589-594
Published Date: 15 October 2020